Lung mass epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
Line 24: | Line 24: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Pulmonology]] | |||
[[Category:Surgery]] |
Revision as of 02:21, 27 November 2017
Lung Mass Microchapters |
Diagnosis |
---|
Treatment |
Lung mass epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Lung mass epidemiology and demographics |
Risk calculators and risk factors for Lung mass epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
The incidence rate of lung masses is approximately 58 per 100 000 individuals in the United States. The incidence of lung masses increases with age; the median age at diagnosis is between 25 to 70 years. Males are more commonly affected with lung masses than females. The male to female ratio is approximately 2 to 1. There is no racial predilection for lung masses.
Epidemiology and Demographics
Incidence
- The incidence rate of malignant lung mass is approximately 58 per 100 000 individuals in the United States
- The incidence rate of lung mass increases with age, tobacco use, and prior cancer
Prevalence
- The prevalence of malignancy among lung mass ranges between 0.2% to 50%
Age
- The median age at diagnosis for malignant lung mass is between 55 to 70 years.
- The median age at diagnosis for benign lung mass is between 20 to 50 years.
Gender
- Males are more commonly affected with lung mass than females. The male to female ratio is approximately 2 to 1.
Ethnicity
- There is no racial predilection of lung mass